» Authors » Dai Akiyama

Dai Akiyama

Explore the profile of Dai Akiyama including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 239
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ito T, Tomizawa E, Yano Y, Akiyama D, Konishi H, Takei K, et al.
Support Care Cancer . 2025 Jan; 33(2):84. PMID: 39786621
Purpose: For cancer patients, prognostication by physicians constitutes a fundamental basis of decision-making to manage the cancer journey, especially with advanced stages of cancer. Various tools such as the palliative...
2.
Ito T, Tomizawa E, Yano Y, Akiyama D, Konishi H, Takei K, et al.
Am J Hosp Palliat Care . 2024 May; 42(2):172-177. PMID: 38748849
Association between physical symptoms and psychosocial difficulties of cancer patients has been reported widely. Nevertheless, the effects of pain and other symptom control on anxiety in such patients have not...
3.
Ishigaki K, Hamada T, Nakai Y, Isayama H, Sato T, Hakuta R, et al.
Dig Dis Sci . 2020 Feb; 65(12):3710-3718. PMID: 32107675
Background: In patients with unresectable hilar malignant biliary obstruction (MBO), bilateral metal stent placement is recommended. However, treatment selection between partially stent-in-stent (SIS) and side-by-side (SBS) methods is still controversial....
4.
Saito T, Nakai Y, Isayama H, Hirano K, Ishigaki K, Hakuta R, et al.
Pancreas . 2018 Jun; 47(7):800-806. PMID: 29851751
Objective: Exocrine pancreatic insufficiency may impair the nutritional status in pancreatic cancer (PC), but the role of pancreatic enzyme replacement therapy (PERT) is not fully evaluated. Therefore, we conducted this...
5.
Takahara N, Isayama H, Nakai Y, Sasaki T, Ishigaki K, Saito K, et al.
Invest New Drugs . 2017 Jan; 35(3):269-276. PMID: 28124197
Objective This study aimed to compare the safety and efficacy of the combination therapy of gemcitabine and S-1 (GS) versus gemcitabine and cisplatin (GC) in patients with advanced biliary tract...
6.
Saito T, Hirano K, Isayama H, Nakai Y, Saito K, Umefune G, et al.
Pancreas . 2017 Jan; 46(3):341-346. PMID: 28099252
Objectives: Although patients with pancreatic cancer (PC) are prone to exocrine pancreatic insufficiency, there are little evidence about pancreatic enzyme replacement therapy (PERT) in patients with PC, especially those receiving...
7.
Nakai Y, Isayama H, Yamamoto N, Matsubara S, Kogure H, Mizuno S, et al.
Dig Endosc . 2016 Nov; 29(2):218-225. PMID: 27862346
Background And Aim: Endoscopic ultrasonography-guided biliary drainage (EUS-BD), first reported as an alternative to percutaneous transhepatic biliary drainage (PTBD) after failed endoscopic retrograde cholangiopancreatography (ERCP), is increasingly reported as a...
8.
Umefune G, Kogure H, Hamada T, Isayama H, Ishigaki K, Takagi K, et al.
J Gastroenterol . 2016 Oct; 52(6):734-745. PMID: 27783206
Background: Procalcitonin is being increasingly used to diagnose and grade acute systemic bacterial infection at an early stage of disease onset. The aim of this prospective study was to evaluate...
9.
Ito Y, Nakai Y, Isayama H, Tsujino T, Hamada T, Umefune G, et al.
Surg Laparosc Endosc Percutan Tech . 2016 Feb; 26(2):150-5. PMID: 26841320
The role of preoperative biliary drainage (PBD) for periampullary and hilar malignancy is still controversial. We retrospectively studied consecutive 144 patients (92 periampullary and 52 hilar malignancy) undergoing surgical resection...
10.
Hirano K, Tada M, Isayama H, Sasahira N, Umefune G, Akiyama D, et al.
J Clin Gastroenterol . 2015 Nov; 50(4):331-7. PMID: 26565969
Objective: To predict the duration of steroid maintenance therapy required to achieve good prognosis in patients with autoimmune pancreatitis. Patients And Methods: The study sample comprised 21 patients with autoimmune...